I think it is difficult question to answer as a lot depends on the success of the products in the pipeline and the revenues they will generate. IMHO- I think around $12 would be realistic, but if they hit big on several areas it could be much higher. Unfortunately, with most medical/pharm stocks there always seems to be delays. Best of luck to all and think everyone will be happy 2 years from now.
That is a great price point- congratulations! I think much bigger things will be on the horizon once they start to generate revenues. At some point revenues/profits will need to come into focus to sustain the upward momentum. Right now a low of people trying to get in on the front end while they have so many different things on the verge of coming to market soon!